| Literature DB >> 31823191 |
A M Hoving1, E E de Vries2, J Mikhal3, G J de Borst2, C H Slump3.
Abstract
PURPOSE: In vitro blood flow studies in carotid artery bifurcation models may contribute to understanding the influence of hemodynamics on carotid artery disease. However, the design of in vitro blood flow studies involves many steps and selection of imaging techniques, model materials, model design, and flow visualization parameters. Therefore, an overview of the possibilities and guidance for the design process is beneficial for researchers with less experience in flow studies.Entities:
Keywords: Design; Imaging techniques; MRI; Model; Optical PIV; Ultrasound
Year: 2019 PMID: 31823191 PMCID: PMC7082306 DOI: 10.1007/s13239-019-00448-9
Source DB: PubMed Journal: Cardiovasc Eng Technol ISSN: 1869-408X Impact factor: 2.495
Figure 1Schematic overview of systematic search.
Figure 2Timeline of all included articles. Each red dot shows one publication.
Characteristics of MRI for in vitro flow studies.
| Author | Sequence | Resolution | Study type | Working fluid | Flow type | Re number | Viscosity | Flow rate (mL/s) | Velocity (cm/s) |
|---|---|---|---|---|---|---|---|---|---|
| Napel 1992 | PC 3D | Th: 0.7 | T | – | St | – | – | 7.1 | 0–40* |
| Wolf 1992 | FT GRE 2D | Th: 5 | T | Paramagnetically doped methylcellulose solution | Pu | – | 0.006 Pa.s | 10 | −3 to 39 |
| Frayne 1993 | PC 3D | S: 0.5 × 0.5 × 0.5 | T–P | Machine tool cutting fluid, water | St | 400 | 0.04 Pa.s | 9 | – |
| Vu 1993 | AFP | Th: 20 | T | – | St | 2219 (Ms) | 10.07 × 10−6 m2/s | – | 14.9 |
| Botnar 2000 | PC | S: 0.5 × 0.5 | T | Glycerin, water | Ph | 488 | 37 × 10−6 m2/s | M: 9.4, P: 28 | – |
| Kohler 2001 | PC 3D | – | T | – | St | – | 0.003 Pa.s | 10 | – |
| Long 2002 | PC 3D | S: 0.63 × 0.63 × 0.8 | T | BMF | St | 330 | 10 | – | |
| Papathana-sopoulou 2003 | PC 3D | S: 0.51 × 0.51 × 1.4 | F | – | Ph | – | 0.0038 Pa.s | M: 7.2, P: 23.6 | – |
| Zhao 2003 | PC 3D | S: 0.51 × 0.51 × 1.05 | T | BMF-S | Ph | 374 | 3.7 × 10−6 m2/s | M: 8.7, P: 19.7 | – |
| Marshall 2004 | PC 3D | S: 0.5 × 0.5 × 1.4 Te: 50 | T | BMF-S | Ph | – | 0.0034 Pa.s | M: 7.2, 2-21* | – |
| Carvalho 2010 | CINE spiral FVE | Te: 23.2 | T | – | – | – | – | – | – |
| Rispoli 2015 | PC 3D | S: 0.5 × 0.5 × 1.0 Te: 91.2 | T | – | – | – | 0.005 Pa.s | – | 0-45* |
| Seong 2015 | PC | S: 0.247 × 0.247 × 1 | F | Glycerin, water | Ph | 666 | 3.6 × 10−3 Pa.s | M: 6, P: 12 | – |
| Cibis 2016 | PC 2D | Several | T | – | Ph | – | 0.001 Pa.s | 0–9* | – |
2D 2 dimensional, 3D 3 dimensional, BMF blood-mimicking fluid, BMF-S blood-mimicking fluid (Shelley), CINE spiral FVE Cine(ma) spiral Fourier velocity encoding, F flow exploration, FT GRE Fourier transform Gradient Recalled Echo, M mean, P peak, PC phase contrast, Ph Physiologic, Pu pulsatile, S Spatial resolution in mm, St Steady/constant, T Technique development/validation, T–P Technique development/validation–Phantom, Te Temporal resolution in ms, Th (slice) thickness in mm, *extracted from figure, “−” NA
Characteristics of optical PIV for in vitro flow studies.
| Author | Laser type | Resolution | Study type | Working fluid | Fluid scatterers | Flow type | Re number | Viscosity | Flow rate (mL/s) | Velocity (cm/s) |
|---|---|---|---|---|---|---|---|---|---|---|
| Bale – Glickman 2003 | C&Pu | Te: 30 | F | Isopropyl alcohol, glycerin | Silver coated hollow glass spheres | St | 13, 185, 410 | 0.15 × 10−6 m2/s | – | P: 40& 49, D: 14&12 |
| Cheung 2010 | – | S: 0.13 × 0.13 | F | Glycerin, water | Rhodamine B fluorescent particles | St | 485 | 6.2 × 10−6 m2/s | P: 12.17 | – |
| Buchmann 2011 | – | S: 1.6 × 1.6 × 1.6 | T | Glycerin, water | Hollow glass spheres | St | 339 | 12.7 × 10−3 Pa.s | – | Max: 37 |
| Zhang 2011 | Pu | S: 0.5 Te: 1428 | T | Dionized water | Cornstarch | Ph | 1700 | 1.0 × 10−6 m2/s | 15.5 | P: 70 |
| Kabinejadian 2013 | Pu | – | F | Glycerin, water | Polyamid particles | Ph | – | 0.0055 Pa.s | M: 47 | – |
| Kefayati 2013 | C | Te: 1000 | F | Water, glycerin, sodium iodide | Rhodamine B-encapsulated microspheres | Ph | 289 | 4.31 × 10−3 Pa.s | M: 6.3 P: 27 | – |
| Kefayati 2014 | C | S: 0.3 × 0.3 Te: 1000 | F | BMF | Polymer fluorescent microspheres | Ph | 312, 473, 789 | 4.31 × 10−3 Pa.s | M: 6.29 P: 27.13 | – |
| Nemati 2015 | Pu | S: 0.3 × 0.3 | F | Glycerin, water | Hollow glass balls | Ph | 512 | – | 40 | – |
| Mokthar 2017 | LED | Te: 120 | F | Glycerin, water | Polyamid particles | St | – | 1.587 × 10−6 m2/s | – | 6 |
| Shimizu 2017 | – | – | T | Polyethylene glycol | Glass particles | St&Si | 0.006 Pa.s | – | 0–25* | |
| Hewlin 2018 | C | – | T-P | Water | Spherical hollow glass particulates | Ph | – | 6.986 × 10−7** | Max: 17.10^3 | Max: 45 |
BMF blood-mimicking fluid, C continuous laser, D diastole, F flow exploration, M mean, Ms measured, P peak, Pu pulsed laser, Ph Physiologic, S spatial resolution in mm, Si sinusoidal, St Steady/constant, T Technique development/validation, T–P Technique development/validation–Phantom, Te Temporal resolution in Hz, Th (slice) thickness in mm, *Extracted from figure, **Kinematic, no units mentioned, “–” NA
Characteristics of ultrasound for in vitro flow studies.
| Author | Group | Protocol/postprocessing | System type | Resolution | Study type | Working fluid | Additional Fluid scatterers | Flow type | Re number | Viscosity | Flow rate (mL/s) | Velocity (cm/s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lai 2013 | HK | PD DCF | R | – | T-P | BMF-S | – | Ph | 242 | 3.95 × 10−6 m2/s | M: 4.5 P: 14 | – |
| Yiu 2013 | HK | CESI | R | Te: 2000, S: 0.15 × 0.15 | T | BMF-S | – | Ph | 80 | 3.95 × 10−6 m2/s | M: 1.5 P: 5 | M: 5.3, P: 35.4 |
| Yiu 2014 | HK | SPW | R | Te: 416 | T | BMF-S | – | Ph | – | 3.95 × 10−6 m2/s | P: 5 | 0-80* |
| Chee 2016 | HK | DCF PWI | C&R | – | T-P | BMF-S | – | Ph | – | – | M: 1.95 P: 6.5 | – |
| Leow 2015 | LO | PW-PI IV | R | Te: 1000 | T | Glycerin, water | MB | Ph | – | – | 4 | – |
| Leow 2018 | LO | PI SPW IV | R | – | T | Glycerin, water | MB | Ph | – | – | – | 0–40* |
| Poepping 2002 | RRI | D | C | Te: 83 | T | BMF-R | – | Ph | 104 | 4.1 × 10−3 Pa.s | M: 9 P: 20 | – |
| Poepping 2004 | RRI | D | C | – | T-P | BMF-R | – | St | – | – | 5 | – |
| Poepping 2010 | RRI | PD | C | Te: 43 | F | BMF-R | – | Ph | – | – | M: 5.1 P: 20 | – |
| Wong 2009 | UWO | D | C | S: 1 | F | BMF-R | – | Ph | 238 | – | M: 6.00 P: 23.46 | – |
| Wong 2013 | UWO | D | C | Te: 83 | F | BMF-R | – | Ph | – | 4.01 × 10−6 m2/s | M: 6.00 P: 23.46 | − 50 to 100* |
| Frayne 1993 | – | C | S: 0.17 × 0.14 × 0.58 | T-P | Machine tool cutting fluid, water | Cellulose particles | St | 400 | 0.04 Pa.s | 9 | – | |
| Zhang 2011 | – | E-PIV | R | Te: 1428, S: 0.5 | T | Water | MB | Ph | 1700 | 1.0 × 10−6 m2/s | 15.5 | P: 70 |
| Shimizu 2017 | – | D | C | – | T | Polyethylene glycol | Glass particles | St&Si | – | 0.006 Pa.s | – | 0 to 25* |
| Jensen 2018 | – | IV | R | S: 1.1 × 1.1 | T | BMF-S | – | Ph | – | 4.1 × 10−3 Pa.s | P: 15 | – |
| Niu 2018 | – | IV | R | Te: 125 | F | – | MB | Ph | – | – | – | – |
BMF blood-mimicking fluid, BMF-S blood-mimicking fluid (Shelley), BMF-R US blood-mimicking fluid: water, glycerol, dextran, surfactant, nylon particles,51C clinical system, CESI Color-encoded speckle imaging, D Doppler, DCF Doppler Color Flow, E-PIV echo particle image velocimetry, F Flow exploration, HK published by research group at University of Hong Kong, HM home-made, IV image velocimetry, LO published by research group at London Imperial College, M mean, MB microbubbles, P peak, Ph Physiologic, PD pulsed Doppler, PI pulse inversion, PWI plane wave imaging, PW-PI plane wave pulse inversion, R research system, RRI published by Robarts Research Institute, S Spatial resolution in mm, Si sinusoidal, SPW steered plane wave, St Steady/constant, T Technique development/validation, T–P Technique development/validation–Phantom, Th (slice) thickness in mm, Te Temporal resolution in Hz, UWO published by research group at The University of Western Ontario, *Extracted from figure, “−” NA
Characteristics of miscellaneous techniques for in vitro flow studies.
| Author | Method | Resolution | Study type | Test fluid | Fluid contrast | Flow type | Re number | Viscosity | Flow rate (mL/s) | Velocity (cm/s) |
|---|---|---|---|---|---|---|---|---|---|---|
| Ku 1985 | LDA | – | F | Glycerin, water | – | Ph | 300 | 12 × 10−6 m2/s | M: 5 P: 13.3 | – |
| Yoshida 1986 | DSA | Te: 30 | T | Water | Contrast medium | St | – | – | 10, 16, 20 | – |
| Couch 1996 | Photo-chromic grid | – | T | Deoderized kerosene | Photo-chromic dye | St | 1200 | 1.8 × 10−6 m2/s | – | −10 to 66 * |
| Ding 2008 | LDA | – | F | Water, glycerin, sodium thiocyanate | Black ink | Ph | 300 | 2.875 × 10−6 m2/s | 3-26* | – |
DSA digital subtraction angiography, LDA laser doppler anemometry, F Flow exploration, M mean, P peak, Ph Physiologic, St Steady/constant, T Technique development/validation, Te Temporal resolution in Hz, *Extracted from figure, “−” NA
Model characteristics of all included papers.
| Author | Fabrication material | Pathology | Geometry | Wall | Origin |
|---|---|---|---|---|---|
| MRI | |||||
| Napel 1992 | – | – | – | – | – |
| Wolf 1992 | – | H & S | – | – | – |
| Frayne 1993 | Polyester resin + TMM (agar-based) | H | AG | TW | HM |
| Vu 1993 | Glass | – | AG | – | HM |
| Botnar 2000 | Silicone | H | PS | WL | HM |
| Kohler 2001 | (1) Plexiglass (Perspex) (2) – | (1) – (2) H | – | – | (1) HM (2) CM |
| Long 2002 | – | – | – | – | CM |
| Papathanasopoulou 2003 | – | H | – | – | CM |
| Zhao 2003 | Acrylic | H | – | – | CM |
| Marshall 2004 | – | H & S | – | – | CM |
| Carvalho 2010 | – | – | – | – | CM |
| Rispoli 2015 | – | H | – | – | CM |
| Seong 2015 | Silicone | H | AG | – | HM |
| Cibis 2016 | – | H | PS | – | HM |
| Optical PIV | |||||
| Bale – Glickman 2003 | Silicone | S | PS | WL | HM |
| Cheung 2010 | Silicone (Sylgard 184) | S | PS | WL | HM |
| Buchmann 2011 | Silicone (Sylgard 184) | S | PS | WL | HM |
| Zhang 2011 | Silicone | H | PS | TW | HM |
| Kabinejadian 2013 | Silicone (PDMS) | H | PS | WL | HM |
| Kefayati 2013 | Silicone (Sylgard 184) | H & S | AG | WL | HM |
| Kefayati 2014 | Silicone (Sylgard 184 | H & S | AG | WL | HM |
| Nemati 2015 | Silicone (PDMS) | S | PS | WL | HM |
| Mokthar 2017 | Perspex | A | AG | WL | HM |
| Shimizu 2017 | Permeable urethane | – | PS | TW | HM |
| Hewlin 2018 | Glass | – | PS | TW | HM |
| Ultrasound | |||||
| Frayne 1993 | Polyester resin + TMM (agar-based) | H | AG | TW | HM |
| Poepping 2002 | Agar | S | AG | WL | HM |
| Poepping 2004 | (1) Silicone (Sylgard 184) + TMM (Agar-based) (2) Agar | S | AG | (1) TW (2) WL | HM |
| Wong 2009 | PTFE (Teflon) | S & U | AG | WL | HM |
| Poepping 2010 | Silicone (Sylgard 184) + TMM (Agar-based | S | AG | TW | HM |
| Zhang 2011 | Silicone | H | PS | TW | HM |
| Lai 2013 | Compliant photopolymer + TMM (Agar-based) | H & S & U | AG | TW | HM |
| Wong 2013 | PTFE (Teflon) | S & U | AG | – | HM |
| Yiu 2013 | PVA | S | AG | WL | HM |
| Yiu 2014 | – | H & S | AG | – | – |
| Leow 2015 | Compliant photopolymer + TMM (Agar-based) | – | AG | TW | HM |
| Chee 2016 | PVA + TMM (Agar-based) | H & S | AG | TW | HM |
| Shimizu 2017 | Permeable urethane | – | PS | TW | HM |
| Jensen 2018 | PVA | H & S | PS | WL | HM |
| Leow 2018 | PVA | H & S | – | WL | HM |
| Niu 2018 | (1) – (2) PVA | H | AG | TW | (1) CM (2) HM |
| Miscellaneous | |||||
| Ku 1985 | Glass and plexiglass | H | AG | – | HM |
| Yoshida 1986 | Vinyl | H | AG | TW | HM |
| Couch 1996 | Plexiglass | H | AG | WL | HM |
| Ding 2008 | Glass | H | AG | TW | HM |
LDA laser doppler anemometry, DSA digital subtraction angiography, PDMS polydimethylsiloxane, PVA polyvinyl alcohol, PTFE polytetrafluoroethylene, H healthy, S stenosed, A aneurysmatic, U ulceration, PS patient-specific, AG average geometry, TW thin-walled, WL wall-less, HM home-made, CM commercial model, “−” NA
Flow visualization parameters.
| Parameter | Description/application | MRI | Opt PIV | US | Miscellaneous |
|---|---|---|---|---|---|
| Velocity | |||||
| (mean/peak) velocity | Often expressed in cm/s and can indicate pathologies, for example velocity increases in narrowed vessels | 4 | 2 | 11 | 1 |
| Velocity vectors/velocity field | Indicate both magnitude and direction | 3 | 10 | 4 | 1 |
| Secondary/circumferential/in plane velocity | Component of velocity orthogonal to largest velocity vector. Compare measurement and CFD results; indicate complex flow; indicate small flow disturbances | 4 | 3 | – | 1 |
| Stream/streak lines | Show pattern of velocity or flow in phantom either in 2D or 3D. Provide information about blood flow disturbances | 1 | 5 | 2 | 1 |
| Velocity profile | Velocity magnitude over one axis through the model. Show differences in measurement and expectation; show differences in flow pattern on several positions; calculate shear stresses | 3 | 5 | 5 | 1 |
| Velocity waveform | Development of blood flow velocity over time. Show differences in measurement and expectation; define measurement accuracy; compare healthy and diseased models | – | 1 | 5 | – |
| Velocity contour | Velocity values in one cross-section of the model. Compare between different measurements | 1 | 3 | – | – |
| Velocity gradient | Compare measurement and CFD results, especially at the walls | – | 1 | 1 | – |
| Flow | |||||
| Flow | Volume of fluid per unit time | 2 | – | – | 1 |
| Flow vectors/patterns | Indicate both magnitude and direction of flow. Show complex flow or recirculation zones at specific timepoint or over a cardiac cycle | – | – | 1 | – |
| Flow waveform | Show flow value in time at a specific position in the phantom. Indicate variations over time and compare measurements with golden standard | 4 | 2 | 1 | – |
| Shear parameters | |||||
| Wall shear rate (WSR) | Defined as flow velocity gradient near the vessel wall | 1 | 1 | 3 | – |
| WSS magnitude | Show distribution of WSS in cross-sections or in graphs to show changes over time. In Pa or N/m2. | 3 | 4 | 1 | – |
| WSS vectors/fields | Indicate both magnitude and direction. Show distribution of WSS in specific part of phantom in both 2D and 3D | 3 | – | – | 1 |
| Oscillatory shear index | Show wall shear stress fluctuations over time | 2 | – | – | – |
| Reynolds shear stress | When shear stress is based on the fluctuating part of the velocity field (derived by Reynolds decomposition). Indicates vortices, areas of turbulent flow | – | 1 | – | – |
| Stress phase angle | Temporal phase angle between WSS and circumferential strain. Plays an important role in arterial disorders | – | – | 1 | – |
| Turbulent/disordered flow | |||||
| Turbulence (intensity) | Shows flow fluctuations over time. Quantifies fluctuations in flow not related to physiologic pulsatile flow | – | 2a, | 4 | – |
| Standard deviation in peak velocity | Quantifies fluctuations in peak flow that are not related to physiologic pulsatile flow | – | – | 1 | – |
| Swirling strength | Quantifies the strength of swirling motions by the imaginary part of the complex eigenvalues of the gradient tensor | – | 2a, | – | – |
| Disturbed flow overlay | Shows a coloured overlay of disordered flow measured by variation in phase signal on MRI | 1 | – | – | – |
| Vorticity (fields) | Quantifies degree of vortexes in space or over time | – | 2 | 1 | – |
| Spectral-broadening index/spectral width | Indicates regions of recirculation, small flow values and spread associated within the velocity spectrum | – | – | 4 | – |
| Doppler spectrograms | Indicates different levels of flow disturbances | – | – | 2a | – |
| Others | |||||
| Pulsatility index | Quantifies pulsatility of blood by calculation of difference between systolic and diastolic velocity | 1 | – | – | – |
| Kinetic energy (KE) | KE can be seen as dynamic pressure in fluid stream. Changes in KE seem to play a role in arterial remodelling | 1 | – | – | – |
aFrom same research group
Benefits and limitations of imaging techniques for the design of in vitro flow studies.
| MRI | Optical PIV | Ultrasound | |
|---|---|---|---|
| Scatter material | |||
| Availability | |||
| Compatibility setup and models | – Limited to transparent and flat-surface models | ||
| Easy to use/learning curve | – Learning curve for protocol/sequence development | – Learning curve for research systems | |
| Translation to clinical patient study | – Limited translation possible when using research-based system |